This study aimed to evaluate and compare the diagnostic and prognostic value of FEN1 with CA153 and CEA as familiar biomarkers in BC to provide further evidence for the serum-based applicability of the proposed markers (37). The gene discussed is FEN1; the disease is breast cancer.